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Ceftizoxime would seem to have potential for use as a single agent in the therapy of polymicrobial infections involving Bacteroides fragilis since it has a much broader spectrum than non-/.-lactam antianaerobe agents and is much more active than other f8-lactam antibiotics, including cefoxitin, when tested against Bacteroides species in conventional minimum inhibitory concentration (MIC) tests. However, hydrolysis of ceftizoxime by a purified fi-lactamase from B. fragilis has been reported, in contrast to the absolute stability of cefoxitin (6).
In Plates were incubated anaerobically for 48 h, and the endpoint was taken as the highest dilution causing complete inhibition of growth. In titrations involving the higher inoculum, a faint haze of growth was sometimes seen which was ignored in assessing the endpoint.
Antibiotic stability assays. Volumes (20 ml each) of BHI-S broth were inoculated with 1 ml of an overnight broth culture of B. fragilis to give an initial inoculum of ca. 5 x 107 bacteria per ml. The tubes ACTIVITY OF CEFTIZ&XIME AGAINST B. FRAGILIS 333 were incubated in a modified version of the multichannel bacterial growth monitoring device described by Mackintosh et al. (5) . When bacterial growth had raised the opacity to a level of 50% of that of a fully grown culture (equivalent to a viable count of ca. 5 x 108 bacteria per ml), sufficient antibiotic was added to achieve the desired concentration, and incubation in the turbidimeter was continued overnight.
After overnight incubation, cultures were centrifuged at 3,000 rpm for 20 min. Supernatants were removed and assayed by using a well-diffusion technique with Staphylococcus aureus NCTC 6571 or Escherichia coli NCTC 10418 as the indicator organism. Standard concentrations of antibiotic in BHI-S broth, but without bacteria, were exposed to identical conditions of incubation and assayed in parallel to take into account any natural instability of the compounds.
Microscopy. Antibiotic-induced morphological changes in bacteria were observed by interferencecontrast microscopy of samples taken from turbidimetric experiments 60 min after addition of antibiotic.
RESULTS
MICs. When tested against a low (103) bacterial inoculum, benzylpenicillin, cephalothin, and cefoxitin exhibited similar activity against six of the seven B. fragilis strains, with benzylpenicilln appearing marginally to be the most active of the three (Table 1) . Ceftizoxime was substantially more active against these strains, with a concentration of 0.25 ug/ml inhibiting all six. The seventh strain was resistant to benzylpenicillin and cephalothin and exhibited an elevated MIC value for ceftizoxime (Table 1) .
When the inoculum was raised 100-fold, MIC values of benzylpenicillin, cephalothin, and ceftizoxime were all markedly increased. Ceftizoxime was particularly dramatically affected by the increase in inoculum size, whereas cefoxitin was hardly affected at all (Table 1) .
Antibiotic assay. No antibacterial activity was detected after overnight incubation of cul- Fig. 1 . Morphological response. The morphological changes induced in B. fragilis strain 1 by various concentrations of the four fB-lactam agents are shown in Fig. 2 . Benzylpenicillin, cefoxitin, and ceftizoxime each evoked filamentation (Fig. 2B) at a low concentration and spheroplast formation (Fig. 2C ) at higher concentrations. Cephalothin induced a different response in that affected cells assumed a bizarre, bloated appearance (Fig. 2D) , whereas filamentation and spheroplast formation were not observed. The concentration ranges over which the various morphological changes were observed are shown diagrammatically in Fig. 3 . Cefoxitin was able to evoke spheroplast fonnation at lower concentrations than was benzylpenicillin, and ceftizoxime was least active in this respect. Essentially similar results were obtained with three other strains examined in this way.
DISCUSSION
Although ceftizoxime showed excellent activity against B. fragilis when tested against low bacterial inocula, this activity was not maintained against the larger bacterial numbers which may be encountered in infection. A simnilar inoculum effect has been noted with the closely related compound cefotaxime (8) and attributed to ,8-lactamase activity on the basis of protection afforded by the ft-lactamase inhibitor, clavulanic acid (8).
In this study, stability tests have shown that the inoculum effect with ceftizoxime is associated with antibiotic destruction by the bacteria and, disappointingly, these new compounds, which otherwise exhibit outstanding activity and stability, appear to share the general susceptibility of earlier cephalosporins to B. fragilis /3-lactamase (7). However, as previously described (7) and confirmed here, the cephamycin antibiotic, cefoxitin, appears fully stable to enzymatic attack by B. fragilis.
When the activity of ceftizoxime was compared with those of other fl-lactam compounds in terms of morphological criteria, it was found that the new cephalosporin was less active than benzylpenicillin or cefoxitin in inducing the cell wall-deficient spheroplasts which lethal concentrations of 8-lactam antibiotics typically induce in susceptible gram-negative rods. However, cef- 
